# Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects

> **NCT01818232** · PHASE1 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-LX4211

## Key facts

- **NCT ID:** NCT01818232
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818232, "Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01818232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*